Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cisplatin Adverse Reaction”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00458887
What this trial is testing

Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin

Who this might be right for
OtotoxicityUnspecified Childhood Solid Tumor, Protocol Specific
Children's Oncology Group 301
Large-scale testing (Phase 3)Study completedNCT00652132
What this trial is testing

Cisplatin With or Without Sodium Thiosulfate in Treating Young Patients With Stage I, II, or III Childhood Liver Cancer

Who this might be right for
Liver CancerOtotoxicity
University of Birmingham 116
Testing effectiveness (Phase 2)Looking for participantsNCT07364747
What this trial is testing

Protective Effect of Acetylcysteine Against Cisplatinum-Induced Ototoxicity: A Randomized Controlled Trial

Who this might be right for
Cisplatin-induced OtotoxicitySensorineural Hearing LossOtotoxicity+1 more
Siriraj Hospital 40
Not applicableUnknownNCT05247671
What this trial is testing

Evaluation of the Effect of Genetic Polymorphisms in ERCC1 and OCT2 on the Occurrence and Severity of Cisplatin-induced Nephrotoxicity

Who this might be right for
Cisplatin Adverse Reaction
Ain Shams University 89
Testing effectiveness (Phase 2)Study completedNCT00006012
What this trial is testing

Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLung CancerRadiation Toxicity
Alliance for Clinical Trials in Oncology 73
Not applicableUnknownNCT05746598
What this trial is testing

Effect of Genetic and Epigenetic Factors on the Clinical Response and Toxicity to Cisplatin Among Egyptian Non-small Cell Lung Cancer Patients

Who this might be right for
Non Small Cell Lung CancerNephropathyCardiotoxicity
Ain Shams University 178
Testing effectiveness (Phase 2)UnknownNCT04817904
What this trial is testing

Evaluation of the Effect of Rosuvastatin on Cisplatin-induced Nephrotoxicity and Ototoxicity

Who this might be right for
Cisplatin Adverse Reaction
Cairo University 65
Testing effectiveness (Phase 2)Looking for participantsNCT07169851
What this trial is testing

Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

Who this might be right for
NauseaVomitingDrug-Related Side Effects and Adverse Reactions+1 more
Eli Lilly and Company 204
Not applicableLooking for participantsNCT06551857
What this trial is testing

The Effect of Cancer Treatments on Speech Perception in Noise, Cognition, and Hearing-Related Quality of Life

Who this might be right for
CancerHearing Loss OtotoxicCognitive Decline+1 more
Turku University Hospital 250
Large-scale testing (Phase 3)Study completedNCT00477607
What this trial is testing

Alpha-Lipoic Acid in Preventing Hearing Loss in Cancer Patients Undergoing Treatment With Cisplatin

Who this might be right for
OtotoxicityUnspecified Adult Solid Tumor
US Department of Veterans Affairs 39
Post-approval studies (Phase 4)Study completedNCT01372904
What this trial is testing

Prevention of Cisplatin-Induced Hearing Loss by Intratympanic Dexamethasone Treatment

Who this might be right for
Cisplatin Ototoxicity
Meir Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT00003269
What this trial is testing

Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors

Who this might be right for
Breast CancerDrug/Agent Toxicity by Tissue/OrganLung Cancer+3 more
Scripps Health 20
Testing effectiveness (Phase 2)Study completedNCT01848457
What this trial is testing

Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy

Who this might be right for
OsteosarcomaNephrotoxicityOtotoxicity
Children's Hospital of Philadelphia 13
Testing effectiveness (Phase 2)UnknownNCT00003251
What this trial is testing

Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganHead and Neck CancerRadiation Toxicity
University of Illinois at Chicago 46
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05039606
What this trial is testing

Clinical Study of Radiotherapy Combined With Nedaplatin Contrast and Cisplatin for the Treatment of Locally Advanced Head and Neck Squamous Carcinoma

Who this might be right for
Head and Neck Squamous Carcinoma
Guiyang Medical University 164
Post-approval studies (Phase 4)Ended earlyNCT04226456
What this trial is testing

Intratympanic Administration of N-acetylcysteine for Protection of Cisplatin-induced Ototoxicity

Who this might be right for
Ototoxic Hearing LossOtotoxic Hearing Loss, BilateralOtotoxicity+1 more
Centre Hospitalier Universitaire Saint Pierre 19
Not applicableNot Yet RecruitingNCT07622407
What this trial is testing

Maximizing Quality of Life After Cancer Through Rehabilitation

Who this might be right for
Head and Neck CancerHearing LossTinnitus+1 more
VA Office of Research and Development 74
Large-scale testing (Phase 3)Study completedNCT01052844
What this trial is testing

Gabapentin in the Prevention of Nausea and Vomiting Induced by Chemotherapy

Who this might be right for
VomitingCisplatin Adverse Reaction
Faculdade de Medicina do ABC 80
Not applicableWithdrawnNCT02382068
What this trial is testing

Dexamethasone in Preventing Hearing Loss in Patients Receiving Cisplatin

Who this might be right for
Malignant NeoplasmOtotoxicity
Aaron Moberly
Testing effectiveness (Phase 2)UnknownNCT06297369
What this trial is testing

Evaluation of the Effect of N-acetylcysteine in Preventing Cisplatin-Induced Toxicities in Cancer Patients

Who this might be right for
Cisplatin Adverse ReactionCisplatin NephrotoxicityCisplatin Induced Peripheral Neuropathy+2 more
Ain Shams University 60
Next Page